Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2026-01-09 @ 12:09 AM
Study NCT ID:
NCT01678105
Status:
COMPLETED
Last Update Posted:
2015-09-17
First Post:
2012-08-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands
Sponsor:
Ontario Clinical Oncology Group (OCOG)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-11
Start Date Type:
None
Primary Completion Date:
2015-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-09
Completion Date Type:
ACTUAL
First Submit Date:
2012-08-23
First Submit QC Date:
None
Study First Post Date:
2012-09-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-09-16
Last Update Post Date:
2015-09-17
Last Update Post Date Type:
ESTIMATED